Sanuwave Health Statistics
Want to see SNWV full AI Analyst Report?
Sanuwave Health (SNWV) Stock Statistics & Valuation Metrics
Total Valuation
Sanuwave Health has a market cap or net worth of $15.31M. The enterprise value is $53.55M.
- Market Cap
- $15.31M
- Enterprise Value
- $53.55M
Share Statistics
Sanuwave Health has 8,602,309 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,602,309
- Owned by Insiders
- 21.98%
- Owned by Institutions
- 9.89%
Financial Efficiency
Sanuwave Health’s return on equity (ROE) is 7.30 and return on invested capital (ROIC) is 19.41%.
- Return on Equity (ROE)
- 7.30
- Return on Assets (ROA)
- 0.32
- Return on Invested Capital (ROIC)
- 19.41%
- Return on Capital Employed (ROCE)
- 0.25
- Revenue Per Employee
- 800.93K
- Profits Per Employee
- 214.78K
- Employee Count
- 55
- Asset Turnover
- 1.18
- Inventory Turnover
- 1.70
Valuation Ratios
The current PE Ratio of Sanuwave Health is 6.07. Sanuwave Health’s PEG ratio is -0.14.
- PE Ratio
- 6.07
- PS Ratio
- 0.38
- PB Ratio
- 5.49
- Price to FCF
- 5.95
- Price to Operating Cash Flow
- 4.76
- PEG Ratio
- -0.14
Income Statement
In the last 12 months, Sanuwave Health had revenue of 44.05M and earned 11.81M in profits. Earnings per share was 1.38.
- Revenue
- 44.05M
- Gross Profit
- 33.97M
- Operating Income
- 4.95M
- Pretax Income
- 11.90M
- Net Income
- 11.81M
- EBITDA
- 19.43M
- Earnings Per Share (EPS)
- 1.38
Cash Flow
In the last 12 months, operating cash flow was 3.29M and capital expenditures -659,000, giving a free cash flow of 2.63M billion.
- Operating Cash Flow
- 3.29M
- Free Cash Flow
- 2.63M
- Free Cash Flow per Share
- 0.31
Dividends & Yields
Sanuwave Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 16.80%
- Earnings Yield
- 16.43%
Stock Price Statistics
- Beta
- 1.47
- 52-Week Price Change
- -94.58%
- 50-Day Moving Average
- 4.62
- 200-Day Moving Average
- 12.29
- Relative Strength Index (RSI)
- 25.90
- Average Volume (3m)
- 79.94K
Important Dates
Sanuwave Health upcoming earnings date is Mar 19, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 11, 2026
- Next Earnings Date
- Mar 19, 2027
- Ex-Dividend Date
- ―
Financial Position
Sanuwave Health as a current ratio of 1.38, with Debt / Equity ratio of 1418.84%
- Current Ratio
- 1.38
- Quick Ratio
- 1.05
- Debt to Market Cap
- 0.09
- Net Debt to EBITDA
- 0.57
- Interest Coverage Ratio
- 0.79
Taxes
In the past 12 months, Sanuwave Health has paid 86.00K in taxes.
- Income Tax
- 86.00K
- Effective Tax Rate
- 0.01
Enterprise Valuation
Sanuwave Health EV to EBITDA ratio is 4.28, with an EV/FCF ratio of 10.50.
- EV to Sales
- 0.67
- EV to EBITDA
- 4.28
- EV to Free Cash Flow
- 10.50
- EV to Operating Cash Flow
- 8.39
Balance Sheet
Sanuwave Health has $6.57M in cash and marketable securities with $18.53M in debt, giving a net cash position of -$11.96M billion.
- Cash & Marketable Securities
- $6.57M
- Total Debt
- $18.53M
- Net Cash
- -$11.96M
- Net Cash Per Share
- -$1.39
- Tangible Book Value Per Share
- -$0.83
Margins
Gross margin is 75.41%, with operating margin of -4.54%, and net profit margin of 6.27%.
- Gross Margin
- 75.41%
- Operating Margin
- -4.54%
- Pretax Margin
- 6.65%
- Net Profit Margin
- 6.27%
- EBITDA Margin
- 15.72%
- EBIT Margin
- 11.86%
Analyst Forecast
The average price target for Sanuwave Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -0.61%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- ―
- AI Score
- 48
